UBS AM’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-72,183
Closed -$558K 2690
2024
Q4
$558K Buy
72,183
+6,105
+9% +$47.2K ﹤0.01% 2540
2024
Q3
$693K Sell
66,078
-4,880
-7% -$51.2K ﹤0.01% 2540
2024
Q2
$830K Buy
70,958
+32,414
+84% +$379K ﹤0.01% 2463
2024
Q1
$812K Hold
38,544
﹤0.01% 2109
2023
Q4
$692K Hold
38,544
﹤0.01% 2211
2023
Q3
$634K Buy
38,544
+13,237
+52% +$218K ﹤0.01% 2187
2023
Q2
$479K Hold
25,307
﹤0.01% 2338
2023
Q1
$479K Sell
25,307
-9,191
-27% -$174K ﹤0.01% 2338
2022
Q4
$782K Sell
34,498
-1,997
-5% -$45.3K ﹤0.01% 1978
2022
Q3
$965K Hold
36,495
﹤0.01% 1988
2022
Q2
$901K Sell
36,495
-1,295
-3% -$32K ﹤0.01% 2023
2022
Q1
$1.25M Hold
37,790
﹤0.01% 2022
2021
Q4
$1.24M Hold
37,790
﹤0.01% 2100
2021
Q3
$1.58M Sell
37,790
-1,653
-4% -$69.3K ﹤0.01% 1936
2021
Q2
$1.53M Buy
39,443
+2,612
+7% +$101K ﹤0.01% 1976
2021
Q1
$1.26M Buy
36,831
+9,941
+37% +$339K ﹤0.01% 1976
2020
Q4
$1.22M Hold
26,890
﹤0.01% 1896
2020
Q3
$740K Hold
26,890
﹤0.01% 1960
2020
Q2
$990K Buy
26,890
+4,525
+20% +$167K ﹤0.01% 1817
2020
Q1
$724K Sell
22,365
-98,759
-82% -$3.2M ﹤0.01% 1821
2019
Q4
$4.96M Buy
121,124
+719
+0.6% +$29.5K ﹤0.01% 1191
2019
Q3
$4.29M Buy
120,405
+691
+0.6% +$24.6K ﹤0.01% 1263
2019
Q2
$6.15M Buy
119,714
+752
+0.6% +$38.6K ﹤0.01% 1127
2019
Q1
$6.82M Buy
118,962
+9,638
+9% +$552K 0.01% 1039
2018
Q4
$4.59M Sell
109,324
-6,427
-6% -$270K ﹤0.01% 1122
2018
Q3
$8.74M Buy
115,751
+103,628
+855% +$7.82M 0.01% 970
2018
Q2
$870K Buy
+12,123
New +$870K ﹤0.01% 1868
2016
Q1
Sell
-108,954
Closed -$1.81M 2658
2015
Q4
$1.81M Sell
108,954
-9,909
-8% -$165K ﹤0.01% 1483
2015
Q3
$2.62M Buy
+118,863
New +$2.62M ﹤0.01% 1301